N Engl J Med. 2008 Feb 14;358(7):700-8. doi: 10.1056/NEJMoa072788.
Nasal CPAP or intubation at birth for very preterm infants.
Morley CJ1, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB; COIN Trial Investigators.
Neonatal Services, Royal Women's Hospital, Melbourne, Australia. colin.morley@rwh.org.au
N Engl J Med. 2008 Apr 3;358(14):1529.
Bronchopulmonary dysplasia is associated with ventilation and oxygen treatment. This randomized trial investigated whether nasal continuous positive airway pressure (CPAP), rather than intubation and ventilation, shortly after birth would reduce the rate of death or bronchopulmonary dysplasia in very preterm infants.
We randomly assigned 610 infants who were born at 25-to-28-weeks' gestation to CPAP or intubation and ventilation at 5 minutes after birth. We assessed outcomes at 28 days of age, at 36 weeks' gestational age, and before discharge.
At 36 weeks' gestational age, 33.9% of 307 infants who were assigned to receive CPAP had died or had bronchopulmonary dysplasia, as compared with 38.9% of 303 infants who were assigned to receive intubation (odds ratio favoring CPAP, 0.80; 95% confidence interval [CI], 0.58 to 1.12; P=0.19). At 28 days, there was a lower risk of death or need for oxygen therapy in the CPAP group than in the intubation group (odds ratio, 0.63; 95% CI, 0.46 to 0.88; P=0.006). There was little difference in overall mortality. In the CPAP group, 46% of infants were intubated during the first 5 days, and the use of surfactant was halved. The incidence of pneumothorax was 9% in the CPAP group, as compared with 3% in the intubation group (P<0.001). There were no other serious adverse events. The CPAP group had fewer days of ventilation.
In infants born at 25-to-28-weeks' gestation, early nasal CPAP did not significantly reduce the rate of death or bronchopulmonary dysplasia, as compared with intubation. Even though the CPAP group had more incidences of pneumothorax, fewer infants received oxygen at 28 days, and they had fewer days of ventilation. (Australian New Zealand Clinical Trials Registry number, 12606000258550.).
Copyright 2008 Massachusetts Medical Society.
Nasal CPAP for very preterm infants. [N Engl J Med. 2008]
Nasal continuous positive airway pressure does not reduce rate of death or bronchopulmonary dysplasia in preterm infants. [J Pediatr. 2008]
10.1056/NEJMoa072788
Publication types, MeSH terms, Substance
Bronchopulmonary Dysplasia/epidemiology
Bronchopulmonary Dysplasia/prevention & control*
Continuous Positive Airway Pressure*/adverse effects
Gestational Age
Infant, Premature
Intubation, Intratracheal*
Oxygen Inhalation Therapy/statistics & numerical data
Pneumothorax/epidemiology
Pneumothorax/etiology
Pulmonary Surfactants/therapeutic use
Respiratory Distress Syndrome, Newborn/drug therapy
Respiratory Distress Syndrome, Newborn/mortality
Respiratory Distress Syndrome, Newborn/therapy*
Pulmonary Surfactants